Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Description

The goal of this pilot study is to evaluate the impact of All4Cure enrollment on patients with multiple myeloma. The main question it aims to answer are: • Does All4Cure effect patient activation as assessed by the PAM-13 survey? Participants will be asked to: * fill out quarterly PAM-13 surveys through the All4Cure website to assess patient activation. * fill out monthly Patient Reported Outcome (PRO) surveys through the All4Cure website. * fill out a baseline and exit All4Cure surveys through the All4Cure website to assess patient perceptions of All4Cure at the beginning and the end of the study.

Conditions

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma, Refractory, Multiple Myeloma with Failed Remission

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this pilot study is to evaluate the impact of All4Cure enrollment on patients with multiple myeloma. The main question it aims to answer are: • Does All4Cure effect patient activation as assessed by the PAM-13 survey? Participants will be asked to: * fill out quarterly PAM-13 surveys through the All4Cure website to assess patient activation. * fill out monthly Patient Reported Outcome (PRO) surveys through the All4Cure website. * fill out a baseline and exit All4Cure surveys through the All4Cure website to assess patient perceptions of All4Cure at the beginning and the end of the study.

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Condition
Multiple Myeloma in Relapse
Intervention / Treatment

-

Contacts and Locations

Fayetteville

Highlands Oncology Group, Fayetteville, Arkansas, United States, 72703

Jacksonville

Cancer Specialists of North Florida, Jacksonville, Florida, United States, 32003

Des Moines

Misson Cancer + Blood, Des Moines, Iowa, United States, 50314

East Syracuse

Hematology-Oncology Associates of Central New York, East Syracuse, New York, United States, 13057

Tulsa

Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma, United States, 74146

Houston

Oncology Consultants, Houston, Texas, United States, 77030

Tacoma

Northwest Medical Specialties PLLC, Tacoma, Washington, United States, 98405

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. have a diagnosis of multiple myeloma.
  • 2. are aged 18 years and older.
  • 3. can read and e-consent to participate in the study.
  • 4. can speak English.
  • 5. can complete surveys at pre-specified intervals.
  • 6. have access to a device that would allow for the completion of surveys (including at home, at work, at the oncologist's office or elsewhere).
  • 7. are cared for by a physician who is enrolled in All4Cure.
  • 1. Patients will be excluded who are unable to engage with All4Cure or are already participants in All4Cure.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

All4Cure,

Study Record Dates

2025-03